# OnCo record paper-sausen-ctdna-pancreatic-resection-nat-commun-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-sausen-ctdna-pancreatic-resection-nat-commun-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-sausen-ctdna-pancreatic-resection-nat-commun-2015" ;
  schema:name "Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients"@en ;
  schema:description "Sequencing tumours and blood from 101 patients found that mutations in chromatin genes go with better survival and that tumour DNA can be found in the blood of 43% of patients with localised cancer, flagging relapse six and a half months before a scan."@en ;
  schema:url <https://onco.cc/key-papers/paper-sausen-ctdna-pancreatic-resection-nat-commun-2015/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/ncomms8686>, <https://pubmed.ncbi.nlm.nih.gov/26154128/> ;
  schema:sameAs <https://doi.org/10.1038/ncomms8686> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Sausen M, Phallen J, Adleff V, et al." ;
  onco:related <https://onco.cc/biomarkers/ctdna-mrd-positive/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:targets <https://onco.cc/targets/arid1a/>, <https://onco.cc/targets/kmt2c/>, <https://onco.cc/targets/kmt2d/> ;
  onco:institutions <https://onco.cc/institutions/johns-hopkins/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/cfdna/> ;
  onco:journals <https://onco.cc/journals/nature-communications/> .